High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH

Human Molecular Genetics

Volumn 10, Issue 3, 2001, Pages 271-282

  Bruder, Carl E G ^a   Hirvelä, Carina ^b   Tapia Paez, Isabel ^a   Fransson, Ingegerd ^a   Segraves, Richard ^c   Hamilton, Greg ^c   Zhang, Xiao Xiao ^c   Evans, D Gareth ^d   Wallace, Andrew J ^d   Baser, Michael E ^e   Zucman Rossi, Jessica ^f   Hergersberg, Martin ^g   Boltshauser, Eugene ^h   Papi, Laura ⁱ   Rouleau, Guy A ^j   Poptodorov, George ^k   Jordanova, Albena ^l   Rask Andersen, Helge ^b   Kluwe, Lan ^m   Mautner, Victor ^m   Sainio, Markku ⁿ   Hung, Gene ^o   Mathiesen, Tiit ^a   Möller, Claes ^p   Pulst, Stefan M ^q   Harder, Henrik ^r   Heiberg, Arvid ^s   Honda, Mariko ^t   Niimura, Michihito ^t   Sahlén, Sigrid ^a   Blennow, Elisabeth ^a   Albertson, Donna G ^c   Pinkel, Daniel ^c   Dumanski, Jan P ^a,b   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ST MARY S HOSPITAL   (United Kingdom)

^e INSERM U434 ^*  (United States)

^f INSERM   (France)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h Department of Pediatrics   (Switzerland)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j MONTREAL GENERAL HOSPITAL   (Canada)

^k UNIVERSITY HOSPITAL 'QUEEN GIOVANNA'   (Bulgaria)

^l Laboratory of Molecular Pathology   (Bulgaria)

^m Klinik Ochsenzoll   (Germany)

ⁿ UNIVERSITY OF HELSINKI   (Finland)

^o HOUSE EAR INSTITUTE   (United States)

^p SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^q CEDARS SINAI MEDICAL CENTER   (United States)

^r LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^s OSLO UNIVERSITY HOSPITAL   (Norway)

^t JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MERLIN;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CHROMOSOME 22Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DNA MICROARRAY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOLECULAR CLONING; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

FALCO COLUMBARIUS;

EID: 0035252636     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.3.271     Document Type: Article

References (34)

1. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis)
2. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling
3. A clinical study of type 2 neurofibromatosis
4. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity
5. Neurofibromatosis 2 in the pediatric age group
6. Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity
7. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations
8. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor supressor
9. Alteration of a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2
10. Screening for germ line mutations in the NF2 gene
11. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes
12. Germ-line mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities
13. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease
14. NF2 gene in neurofibromatosis type 2 patients
15. A disease associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukemia inhibitory factor locus
16. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus
17. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2
18. A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes
19. Pre-symptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers
20. Severe phenotype of the neurofibromatosis type 2 in a patient with a 7.4 Mbp constitutional deletion on chromosome 22; possible localization of a neurofibromatosis type 2 modifier gene?
21. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
22. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
23. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
24. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
25. Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12
26. Characterization of a new member of the human β-adaptin gene family from chromosome 22q12, a candidate meningioma gene
27. Misleading linkage results in an NF2 presymptomatic test owing to mosaicism
28. Somatic mosaicism: A common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis
29. Mosaicism in sporadic neurofibromatosis 2 patients
30. The DNA sequence of human chromosome 22
31. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
32. Fifty probands with extra structurally abnormal chromosomes characterized by fluorescence in situ hybridization
33. Fine mapping of the constitutional translocation t(11;22)(q23;q11)